Switch to:

Amplia Therapeutics EV-to-EBITDA

: -8.55 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Amplia Therapeutics's enterprise value is $12.00 Mil. Amplia Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was $-1.40 Mil. Therefore, Amplia Therapeutics's EV-to-EBITDA for today is -8.55.

OTCPK:INNMF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.2   Med: -0.7   Max: 0.9
Current: -9.54
-74.2
0.9

During the past 8 years, the highest EV-to-EBITDA of Amplia Therapeutics was 0.90. The lowest was -74.20. And the median was -0.70.

OTCPK:INNMF's EV-to-EBITDA is ranked lower than
99.99% of the 273 Companies
in the Biotechnology industry.

( Industry Median: 29.72 vs. OTCPK:INNMF: -9.54 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-09-30), Amplia Therapeutics's stock price is $0.13. Amplia Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.03. Therefore, Amplia Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Amplia Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Amplia Therapeutics Annual Data
Jun13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only -7.33 -18.69 -3.00 -2.34 -1.10

Amplia Therapeutics Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.00 0.00 -2.34 0.00 -1.10
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Amplia Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Amplia Therapeutics's EV-to-EBITDA falls into.


Amplia Therapeutics EV-to-EBITDA Calculation

Amplia Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12.000/-1.4036069651741
=-8.55

Amplia Therapeutics's current Enterprise Value is $12.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplia Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was $-1.40 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Amplia Therapeutics  (OTCPK:INNMF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Amplia Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.13/-0.02646144278607
=

Amplia Therapeutics's share price for today is $0.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplia Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.03.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Amplia Therapeutics EV-to-EBITDA Related Terms

Amplia Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)